Shane Bowen
Hoofd Techniek/Wetenschap/O&O bij STANDARD BIOTOOLS INC.
Profiel
Shane Bowen is the founder of Palamedrix, Inc. He currently holds the position of Chief Technology Officer at Standard BioTools, Inc.
Actieve functies van Shane Bowen
Bedrijven | Functie | Begin |
---|---|---|
STANDARD BIOTOOLS INC. | Hoofd Techniek/Wetenschap/O&O | 05-01-2024 |
Palamedrix, Inc.
Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
STANDARD BIOTOOLS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Palamedrix, Inc.
Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Commercial Services |